ID: ALA5277785

Max Phase: Preclinical

Molecular Formula: C19H14N4S4

Molecular Weight: 426.62

Associated Items:

Representations

Canonical SMILES:  Cc1c(-c2csc(N)n2)sc2sc(-c3csc(N)n3)c(-c3ccccc3)c12

Standard InChI:  InChI=1S/C19H14N4S4/c1-9-13-14(10-5-3-2-4-6-10)16(12-8-25-19(21)23-12)27-17(13)26-15(9)11-7-24-18(20)22-11/h2-8H,1H3,(H2,20,22)(H2,21,23)

Standard InChI Key:  ZAWLMTVXUDXOBL-UHFFFAOYSA-N

Associated Targets(Human)

PC-3 62116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 426.62Molecular Weight (Monoisotopic): 426.0101AlogP: 6.35#Rotatable Bonds: 3
Polar Surface Area: 77.82Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.06CX LogP: 6.23CX LogD: 6.23
Aromatic Rings: 5Heavy Atoms: 27QED Weighted: 0.35Np Likeness Score: -0.57

References

1. Sharma PC, Bansal KK, Sharma A, Sharma D, Deep A..  (2020)  Thiazole-containing compounds as therapeutic targets for cancer therapy.,  188  [PMID:31926469] [10.1016/j.ejmech.2019.112016]

Source